CEX Capital joins PlusQuam Pharma as a strategic partner to drive its growth in the pharmaceutical sector

by CEX Capital

PlusQuam Pharma is a pharmaceutical company specialized in the development of food supplements, medical devices, and cosmetic products, operating in the areas of urological health, women’s health, d...

Read more

CDTI and the EIF invest €74.7 million in the Asabys Innvierte Tech Transfer fund

by CDTI Innovación

The Asabys Innvierte Tech Transfer FCRE fund, specialised in biotechnology and medical technologies, will invest in the creation and development of innovative companies in the field of deep-tech appli...

Read more

Archipélago Next accelerates the deployment of its second fund with three new additions to its portfolio

by Archipélago Next

Archipélago Next continues to accelerate the deployment of its second fund with the addition of three new companies to its portfolio: TietAI, Dolfin and Fresh People. Although operating in different ...

Read more

Saesco Medical, a Miura Partners portfolio company, acquires Sangüesa and Italian company Medcomp

by Miura Partners

The group has announced the acquisition of the Italian company Medcomp, as well as the purchase of the production unit of Catalan medical supplier Sangüesa. With these two transactions, Saesco reache...

Read more

Columbus Venture Partners and Concentric co-lead a funding round in Visium to accelerate AI adoption in the pharmaceutical and biotechnology industries

by Columbus Venture Partners

Visium has grown to a team of 100 AI experts across Europe and has delivered more than 250 AI and data solutions for global leaders in life sciences, specialty chemicals and other regulated industries...

Read more

Alantra advises FLOTTE on the sale of sanotact to Avista Healthcare Partners and Damier

by Alantra

The transaction represents an important milestone in sanotact’s continued development. Avista brings deep experience in consumer healthcare across North America and Europe, while Damier contributes ...

Read more

Mergers and acquisitions in the health sector: connecting innovation and the investor ecosystem

by Albia Capital Partners

In 2025, 48% of M&A transactions in the healthcare sector in Spain involved the direct or indirect participation of financial investors, highlighting the growing interest of capital in this space

Read more

The rise of M&A in dermatology and cosmetics: key trends and market opportunities

by Albia Capital Partners

The dermatology and cosmetics sector continues to position itself as one of the most attractive areas within consumer markets, supported by strong structural demand linked to wellness, health, and per...

Read more

SOKAI secures €64.5 million in funding to develop its life sciences hub in San Sebastián

by Buenavista Equity Partners

The total planned investment for the development is around €80 million, with the asset expected to be partially operational at the beginning of 2027. This financing represents one of the most signif...

Read more

Cuatrecasas advises H.I.G. Capital on the acquisition of a majority stake in the Vitaly Group

by Cuatrecasas

Following its acquisition of the Avanta Group last year, H.I.G. Capital continues its expansion in the Iberian occupational health and safety (OHS) services market through the acquisition of a majorit...

Read more

Ona Therapeutics Raises $86.6 Million Series B co-led by Columbus Venture Parrners and Mérieux Equity Partners to Advance First-in-Class ADCs into Clinical Development

by Columbus Venture Partners

The round was co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from additional investors COFIDES and Korys, alongside all existing investors Alta Life...

Read more

Cuatrecasas advises Columbus Partners and Mérieux Equity Partners on their investment in Ona Therapeutics, which is developing new cancer treatments

by Cuatrecasas

Cuatrecasas advised Columbus Venture Partners and Mérieux Equity Partners on their participation as co-lead investors in Ona Therapeutics Series B financing. Ona Therapeutics is a pioneering biopharm...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Everwood Capital acquires Tudefrigo and ...

by Everwood Capital

The company generates annual revenues of approximately €90 million a...

Photos Stream